China BCT Pharmacy Group, Inc.
CNBI · OTC
3/31/2013 | 12/31/2012 | 9/30/2012 | 6/30/2012 | |
|---|---|---|---|---|
| Market Cap | $9,920 | $7,631 | $24,800 | $57,232 |
| - Cash | $22,803 | $21,609 | $19,367 | $19,681 |
| + Debt | $16,323 | $16,245 | $11,461 | $10,105 |
| Enterprise Value | $3,440 | $2,267 | $16,894 | $47,656 |
| Revenue | $66,577 | $54,123 | $55,403 | $61,098 |
| % Growth | 23% | -2.3% | -9.3% | – |
| Gross Profit | $11,246 | $8,073 | $10,748 | $13,351 |
| % Margin | 16.9% | 14.9% | 19.4% | 21.9% |
| EBITDA | $6,719 | $3,261 | $6,363 | $9,225 |
| % Margin | 10.1% | 6% | 11.5% | 15.1% |
| Net Income | $4,590 | $1,561 | $4,153 | $6,432 |
| % Margin | 6.9% | 2.9% | 7.5% | 10.5% |
| EPS Diluted | 0.09 | 0.041 | 0.08 | 0.13 |
| % Growth | 120% | -48.9% | -38.5% | – |
| Operating Cash Flow | $2,662 | $1,150 | -$1,154 | -$11,131 |
| Capital Expenditures | -$1,552 | -$3,169 | -$478 | -$1,063 |
| Free Cash Flow | $1,110 | -$2,019 | -$1,632 | -$12,194 |